GlassScriptPhysician profile
Kevin S Jensen
NPI 1942527734
$29,527.69
in general payments reported to CMS, 2019-2025
28 companies · $3,104 in 2025
The $3,104 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $48.87 · 2021: $20K · 2022: $1,919 · 2023: $1,458 · 2024: $3,048 · 2025: $3,104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,073 · Food and Beverage: $2,014 · Education: $2,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,073.18 |
| Food and Beverage | $2,013.72 |
| Education | $2,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $27,641.60 | 2021-2025 | Da Vinci Surgical System |
| Hologic Sales and Service, LLC | $261.07 | 2021-2024 | Myosure Tissue Removal Device, Aptima, Thinprep 2000 Processor |
| Astellas Pharma US INC | $259.62 | 2023-2024 | Veozah |
| Abbvie INC. | $220.31 | 2019-2025 | |
| Biogen, INC. | $173.38 | 2024-2025 | Zurzuvae |
| Duchesnay USA Incorporated | $123.93 | 2019 | |
| Exeltis, USA INC. | $102.19 | 2022-2025 | Slynd |
| Organon LLC | $85.14 | 2022-2025 | Nexplanon, Jada System |
| Medtronic, INC. | $80.53 | 2022-2023 | Truclear |
| Merck Sharp & Dohme LLC | $75.18 | 2019-2023 | Gardasil 9 |
| Coopersurgical, INC. | $61.38 | 2022-2025 | Ally II Ups |
| Axonics, INC. | $55.28 | 2020-2024 | Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $52.44 | 2019-2024 | |
| Monaghan Medical Corporation | $33.52 | 2023 | Aerobika |
| Pfizer INC. | $33.40 | 2024-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $30.45 | 2023 | Dermabond Prineo |
| Nevro Corp. | $27.65 | 2019 | |
| Conmed Corporation | $25.15 | 2023 | Airseal |
| Daiichi Sankyo INC. | $24.93 | 2019 | |
| Dexcom, INC. | $21.43 | 2025 | Dexcom G6 Transmitter |
| Innovation Technologies INC | $20.95 | 2024 | Irrisept |
| Coloplast Corp | $20.01 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $19.55 | 2021 | |
| Horizon Therapeutics Plc | $18.58 | 2020 | |
| Baxter Healthcare | $17.66 | 2023 | Adept |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Exact Sciences Corporation | $14.18 | 2023 | Cologuard Collection Kit |
| Scynexis, INC. | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.